Reuters logo
Fitch Affirms Quest Diagnostics at 'BBB'; Outlook Stable
September 27, 2017 / 3:34 PM / 3 months ago

Fitch Affirms Quest Diagnostics at 'BBB'; Outlook Stable

(The following statement was released by the rating agency) NEW YORK, September 27 (Fitch) Fitch Ratings has affirmed the ratings of Quest Diagnostics Incorporated (NYSE: DGX) including the Issuer Default Rating (IDR) at 'BBB'. The Rating Outlook is Stable. A full list of ratings can be found at the end of the release. KEY RATING DRIVERS Leading Market Position: Quest is the largest independent player as measured by segment revenues in the relatively fragmented and highly competitive U.S. clinical laboratory market. Such scale affords the opportunity for comparatively efficient operations and supplies sourcing and the ability to drive associated margin improvement following M&A. These advantages should allow DGX to improve its relative cost position which is a competitive advantage given the prominence that pricing plays in customer decisions. Continued Improvements in Operating Performance: Quest's focus on operational improvement has helped to drive margin improvement that has been accompanied by positive organic growth in each fiscal quarter since fourth-quarter 2014. Fitch expects low single-digit organic growth through the rating horizon, benefitting from moderating pricing pressure other than the implementation of the Protecting Access to Medicare Act (PAMA), cost efficiencies, and favorable business mix driven by strong growth in Quest's gene-based and esoteric testing business. Fitch view's Quest's partnerships with Safeway (Not Rated) and Wal-Mart Stores (AA/Stable) favorably as they are low-capex expansions of Quest's market reach and, if successful, may result in lower lease-adjusted leverage in the long-run. PAMA Uncertainty Lingers: The Centers for Medicare and Medicaid Services (CMS) has moved forward with potential revisions to reimbursement schedules for clinical labs provided under Medicare as a result of PAMA. CMS announced initial rates on Friday, Sept. 22 and is accepting comment letters through late October. In our ratings case forecast, Fitch has assumed that the approximately 10%-15% of revenues that DGX derives from Medicare will be negatively affected by the maximum 10% price reduction per year. The rate cuts come in spite of the industry's objections that other higher cost laboratories were excluded from the database and did not fairly represent costs and their arguments could result in another delay. Fitch has assumed that if PAMA is implemented as currently contemplated, DGX would adjust capital deployment to maintain its current leverage profile. Over the long term, PAMA could place greater pressure on smaller, independent laboratories than on DGX and allow for increased contract wins or acquisition opportunities. Stable Leverage: Fitch expects leverage (gross debt/EBITDA) will sustain around 2.5x which is consistent with what Fitch believes to be management's long-term target. Fitch does not expect the company to prioritize debt repayment in the current low interest rate environment, so any near-term de-levering will likely result from EBITDA gains. Fitch expects capital deployment will focus on driving growth through acquisitions (management is targeting 1%-2% of revenue growth per year from acquisitions) and returning cash to shareholders through dividends and share buybacks. DERIVATION SUMMARY Quest Diagnostic's 'BBB' rating reflects the issuer's leading position and scale in the competitive U.S. clinical laboratory industry. Quest's reach and scale provide meaningful competitive advantages on fixed costs and supply sourcing, which helps to maintain or grow margins amid pricing headwinds. Strong cash conversion of operating EBITDA enables the issuer to maintain leverage around 2.5x despite allocating most free cash flow towards acquisitions, dividends and share repurchases. Within the clinical laboratory industry, Fitch views Quest's position as competitive with LabCorp. (Not Rated) and stronger than that of the smaller more regionally focused private laboratories. KEY ASSUMPTIONS Fitch's key assumptions within our rating case for the issuer include: -Revenues: Organic top-line growth to approximate 0%-1% per year through volume and mix tailwinds offset by continued pricing pressures including PAMA. Fitch has assumed DGX will generate an additional 1%-2% through acquisitions. -Margins: Fitch has assumed limited margin expansion through the rating horizon but recognizes additional improvements through the issuer's Invigorate program could provide upside to the forecast. -Cash Flows and Capital Deployment: Fitch has assumed approximately $250 million per year of acquisitions to achieve the aforementioned growth along with dividends and share buybacks of approximately $525 million to $625 million per year. -Credit Metrics: The aforementioned assumptions should lead to leverage sustaining around 2.5x through the rating horizon. RATING SENSITIVITIES Future Developments That May, Individually or Collectively, Lead to Positive Rating Action -Positive rating actions are not likely in the near term, as Fitch expects Quest will maintain gross leverage at or near 2.5x for the foreseeable future. -Over the longer term, an upgrade to 'BBB+' could be considered if the company committed to maintaining gross debt/EBITDA at 2.2x or below, accompanied by an outlook for positive organic growth and margin expansion. Organic growth may be challenged by a persistently constrained reimbursement environment, making meaningful EBITDA growth dependent on cost savings and/or M&A funded with discretionary cash flows. Future Developments That May, Individually or Collectively, Lead to Negative Rating Action -A negative rating action could result from a reversion to negative growth and margin trends coupled with an inability to drive cost savings under the expanded Invigorate program. -Ongoing EBITDA declines and/or debt-funded transactions contributing to gross debt\ EBITDA sustained around 2.7x or above could drive a downgrade to 'BBB-'. -Operating cash flow trending below $500 million without an adjustment to the firm's dividend or capital spending could also pressure the ratings. LIQUIDITY No Near-Term Maturities & Ample Sources: Quest's next bond maturity is the $300 million due April 2019. Quest has access to an undrawn $750 million revolver due April 2019, $529 million of availability under the $600 million A/R securitization facility due October 2017, and had cash on hand of $314 million at June 30, 2017 (21% considered permanently reinvested outside the U.S.). Fitch classifies only the amount held overseas as not readily available. Quest's liquidity also benefits from the forecasted $1 billion per year of cash flow from operations. FULL LIST OF RATING ACTIONS Fitch has affirmed the ratings as follows: Quest Diagnostics, Inc. --Long-Term IDR at 'BBB'; --Senior unsecured revolving credit facility at 'BBB'; --Senior unsecured notes at 'BBB'. The Rating Outlook is Stable. Contact: Primary Analyst Britton Costa, CFA Senior Director +1-212-908-0524 Fitch Ratings, Inc. 33 Whitehall Street New York, NY 10004 Secondary Analyst Benjamin Immordino, CFA Associate Director +1-212-908-9163 Committee Chairperson Michael Weaver Managing Director +1-312-368-3156 Summary of Financial Statement Adjustments - Financial statement adjustments that depart materially from those contained in the published financial statements of the relevant rated entity or obligor are disclosed below: --Fitch has capitalized operating leases at 8x when referencing lease-adjusted leverage metrics; --Fitch classifies cash held overseas as not readily available; --Fitch added back stock-based compensation, restructuring expenses and other non-recurring and/or non-cash items to EBITDA; --Fitch has netted provision for doubtful accounts and changes in accounts receivable when calculating FFO and working capital. Media Relations: Alyssa Castelli, New York, Tel: +1 (212) 908 0540, Email: alyssa.castelli@fitchratings.com. Additional information is available on www.fitchratings.com Applicable Criteria Corporate Rating Criteria (pub. 07 Aug 2017) here Non-Financial Corporates Notching and Recovery Ratings Criteria (pub. 16 Jun 2017) here Parent and Subsidiary Rating Linkage (pub. 31 Aug 2016) here Additional Disclosures Dodd-Frank Rating Information Disclosure Form here Solicitation Status here#solicitation Endorsement Policy here ALL FITCH CREDIT RATINGS ARE SUBJECT TO CERTAIN LIMITATIONS AND DISCLAIMERS. PLEASE READ THESE LIMITATIONS AND DISCLAIMERS BY FOLLOWING THIS LINK: here. IN ADDITION, RATING DEFINITIONS AND THE TERMS OF USE OF SUCH RATINGS ARE AVAILABLE ON THE AGENCY'S PUBLIC WEB SITE AT WWW.FITCHRATINGS.COM. PUBLISHED RATINGS, CRITERIA, AND METHODOLOGIES ARE AVAILABLE FROM THIS SITE AT ALL TIMES. FITCH'S CODE OF CONDUCT, CONFIDENTIALITY, CONFLICTS OF INTEREST, AFFILIATE FIREWALL, COMPLIANCE, AND OTHER RELEVANT POLICIES AND PROCEDURES ARE ALSO AVAILABLE FROM THE CODE OF CONDUCT SECTION OF THIS SITE. DIRECTORS AND SHAREHOLDERS RELEVANT INTERESTS ARE AVAILABLE here. FITCH MAY HAVE PROVIDED ANOTHER PERMISSIBLE SERVICE TO THE RATED ENTITY OR ITS RELATED THIRD PARTIES. DETAILS OF THIS SERVICE FOR RATINGS FOR WHICH THE LEAD ANALYST IS BASED IN AN EU-REGISTERED ENTITY CAN BE FOUND ON THE ENTITY SUMMARY PAGE FOR THIS ISSUER ON THE FITCH WEBSITE. Copyright © 2017 by Fitch Ratings, Inc., Fitch Ratings Ltd. and its subsidiaries. 33 Whitehall Street, NY, NY 10004. Telephone: 1-800-753-4824, (212) 908-0500. Fax: (212) 480-4435. Reproduction or retransmission in whole or in part is prohibited except by permission. All rights reserved. In issuing and maintaining its ratings and in making other reports (including forecast information), Fitch relies on factual information it receives from issuers and underwriters and from other sources Fitch believes to be credible. Fitch conducts a reasonable investigation of the factual information relied upon by it in accordance with its ratings methodology, and obtains reasonable verification of that information from independent sources, to the extent such sources are available for a given security or in a given jurisdiction. The manner of Fitch’s factual investigation and the scope of the third-party verification it obtains will vary depending on the nature of the rated security and its issuer, the requirements and practices in the jurisdiction in which the rated security is offered and sold and/or the issuer is located, the availability and nature of relevant public information, access to the management of the issuer and its advisers, the availability of pre-existing third-party verifications such as audit reports, agreed-upon procedures letters, appraisals, actuarial reports, engineering reports, legal opinions and other reports provided by third parties, the availability of independent and competent third- party verification sources with respect to the particular security or in the particular jurisdiction of the issuer, and a variety of other factors. Users of Fitch’s ratings and reports should understand that neither an enhanced factual investigation nor any third-party verification can ensure that all of the information Fitch relies on in connection with a rating or a report will be accurate and complete. Ultimately, the issuer and its advisers are responsible for the accuracy of the information they provide to Fitch and to the market in offering documents and other reports. In issuing its ratings and its reports, Fitch must rely on the work of experts, including independent auditors with respect to financial statements and attorneys with respect to legal and tax matters. Further, ratings and forecasts of financial and other information are inherently forward-looking and embody assumptions and predictions about future events that by their nature cannot be verified as facts. As a result, despite any verification of current facts, ratings and forecasts can be affected by future events or conditions that were not anticipated at the time a rating or forecast was issued or affirmed. The information in this report is provided “as is” without any representation or warranty of any kind, and Fitch does not represent or warrant that the report or any of its contents will meet any of the requirements of a recipient of the report. A Fitch rating is an opinion as to the creditworthiness of a security. This opinion and reports made by Fitch are based on established criteria and methodologies that Fitch is continuously evaluating and updating. Therefore, ratings and reports are the collective work product of Fitch and no individual, or group of individuals, is solely responsible for a rating or a report. The rating does not address the risk of loss due to risks other than credit risk, unless such risk is specifically mentioned. Fitch is not engaged in the offer or sale of any security. All Fitch reports have shared authorship. Individuals identified in a Fitch report were involved in, but are not solely responsible for, the opinions stated therein. The individuals are named for contact purposes only. A report providing a Fitch rating is neither a prospectus nor a substitute for the information assembled, verified and presented to investors by the issuer and its agents in connection with the sale of the securities. Ratings may be changed or withdrawn at any time for any reason in the sole discretion of Fitch. Fitch does not provide investment advice of any sort. Ratings are not a recommendation to buy, sell, or hold any security. Ratings do not comment on the adequacy of market price, the suitability of any security for a particular investor, or the tax-exempt nature or taxability of payments made in respect to any security. Fitch receives fees from issuers, insurers, guarantors, other obligors, and underwriters for rating securities. Such fees generally vary from US$1,000 to US$750,000 (or the applicable currency equivalent) per issue. In certain cases, Fitch will rate all or a number of issues issued by a particular issuer, or insured or guaranteed by a particular insurer or guarantor, for a single annual fee. Such fees are expected to vary from US$10,000 to US$1,500,000 (or the applicable currency equivalent). The assignment, publication, or dissemination of a rating by Fitch shall not constitute a consent by Fitch to use its name as an expert in connection with any registration statement filed under the United States securities laws, the Financial Services and Markets Act of 2000 of the United Kingdom, or the securities laws of any particular jurisdiction. Due to the relative efficiency of electronic publishing and distribution, Fitch research may be available to electronic subscribers up to three days earlier than to print subscribers. For Australia, New Zealand, Taiwan and South Korea only: Fitch Australia Pty Ltd holds an Australian financial services license (AFS license no. 337123) which authorizes it to provide credit ratings to wholesale clients only. Credit ratings information published by Fitch is not intended to be used by persons who are retail clients within the meaning of the Corporations Act 2001

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below